Crossmark

The Reporting on ERAS Compliance, Outcomes, and Elements Research (RECOvER) Checklist: A Joint Statement by the ERAS® and ERAS® USA Societies

Crossref DOI link: https://doi.org/10.1007/s00268-018-4753-0

Published Online: 2018-08-16

Published Print: 2019-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elias, Kevin M.

,

Stone, Alexander B.

McGinigle, Katharine

Tankou, Jo’An I.

Scott, Michael J.

Fawcett, William J.

Demartines, Nicolas

Lobo, Dileep N.

Ljungqvist, Olle

Urman, Richard D.
License Information

Text and Data Mining valid from 2018-08-16
More Information

Article History

First Online: 16 August 2018

Compliance with ethical standards

:

: MS has received honoraria from Merck, Baxter, Deltex and Cheetah Medical for lecturing and travel expenses. RU has received research funding from Medtronic, Mallinckrodt, Merck, and honorarium from 3M. DNL has received unrestricted research funding and speaker’s honoraria from Fresenius Kabi, BBraun and Baxter Healthcare for unrelated work. OL has received honoraria from Merck, Fresenius Kabi, Nutricia, Baxter and Abbot for advice or lecturing and travel expenses. OL is a shareholder of Encare AB, Sweden, an IT company involved in audit. WJF reports honoraria from Merck, Baxter, Grunethal and Smiths for lecturing and travel expenses. The remaining authors have no disclosures.